non-small cell lung cancer
Conditions
Interventions
Experimental group:Orally take the agreed - upon prescription Sanchong Tongluo Sanjie CapsulesConventional Western anti - cancer treatment Conventional traditional Chinese medicine treatment
control group:Conventional Western anti - cancer treatment , Conventional traditional Chinese medicine treatment
Sponsors
Shenzhen Bao'an Traditional Chinese Medicine Hospital
Eligibility
Sex/Gender
All
Age
20 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1: treated patients with stage IV NSCLC who meet the diagnostic criteria. 2: Patients aged between 20 and 80 years old. 3: Patients with an estimated survival period of more than 3 months 4: Patients with a Karnofsky Performance Status (KPS) score of = 60 points. 5: Patients or their agents are able to read understand and fill out relevant forms
Exclusion criteria
Exclusion criteria: 1: The pathological diagnosis is unclear. 2: Patients who have other malignancies concurrently. 3: Patients with severe underlying diseases such as those with liver or kidney failure who cannot tolerate the treatment. 4: Pregnant or lactating women and patients with mental illnesses 5: Patients who are allergic to the study drugs. 6: Patients who are currently participating in other clinical trials.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Short-term curative effect; | — |
Secondary
| Measure | Time frame |
|---|---|
| Squamous Cell Carcinoma Antigen;Plasma D-dimer;Traditional Chinese Medicine symptom score and therapeutic effect;Cytokeratin 19 Fragment(CYFRA21-1);Neuron-Specific Enolase;Carcinoembryonic Antigen(CEA);Metabolomics; | — |
Countries
China
Contacts
Public ContactLIYang
Shenzhen Bao'an Traditional Chinese Medicine Hospital
Outcome results
None listed